Monopar Therapeutics Inc
MNPR
NASDAQ
Biotechnology
$113.04
USD
+2.63 (+2.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $737.90M
Volume 165.7K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
IMMX | Immix Biopharma Inc | $781.21M | - | - | - | |
RIGL | Rigel Pharmaceuticals Inc | $780.54M | 2.42 | +3.3% | - | |
BBOT | BridgeBio Oncology Therapeutics Inc | $743.39M | - | - | - | |
CTMX | CytomX Therapeutics Inc | $738.68M | - | -87.0% | - | |
MNPR | Monopar Therapeutics Inc | $737.90M | - | - | - | |
GYRE | Gyre Therapeutics Inc | $736.94M | - | +16.3% | - | |
ACHV | Achieve Life Sciences Inc | $725.46M | - | -89.3% | - | |
NGNE | Neurogene Inc | $719.91M | - | - | - | |
RGNX | Regenxbio Inc | $701.72M | - | +12.0% | - | |
STTK | Shattuck Labs Inc | $661.53M | - | -78.3% | - |
Top Peer by Growth
Gyre Therapeutics Inc
+16.3% YoY Revenue
Lowest P/E Ratio
Rigel Pharmaceuticals Inc
2.42x P/E
Best 1-Year Return
Shattuck Labs Inc
+882.3% Return